Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs

Cancer is the second most common cause of death in the United States, accounting for 602,350 deaths in 2020. Cancer-related death rates have declined by 27% over the past two decades, partially due to the identification of novel anti-cancer drugs. Despite improvements in cancer treatment, newly appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Tyler C., Springs, Kendra, Morningstar, Jordan E., Mills, Catherine, Stoddard, Andrew, Guo, Lilong, Moore, Kelsey, Gensemer, Cortney, Biggs, Rachel, Petrucci, Taylor, Kwon, Jennie, Stayer, Kristina, Koren, Natalie, Dunne, Jaclyn, Fulmer, Diana, Vohra, Ayesha, Mai, Le, Dooley, Sarah, Weninger, Julianna, Peterson, Yuri, Woster, Patrick, Dix, Thomas A., Norris, Russell A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227314/
https://www.ncbi.nlm.nih.gov/pubmed/35744803
http://dx.doi.org/10.3390/molecules27123678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227314/
https://www.ncbi.nlm.nih.gov/pubmed/35744803
http://dx.doi.org/10.3390/molecules27123678

Ejemplares similares